| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 29.629 | 32.387 | 67.727 | 65.912 | 65.435 |
| Total Income - EUR | - | - | - | - | - | 29.629 | 32.387 | 67.727 | 66.640 | 65.435 |
| Total Expenses - EUR | - | - | - | - | - | 7.666 | 29.747 | 49.320 | 50.651 | 46.590 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 21.963 | 2.641 | 18.407 | 15.989 | 18.845 |
| Net Profit/Loss - EUR | - | - | - | - | - | 21.144 | 1.802 | 16.645 | 15.330 | 16.882 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 2 | 2 |
Check the financial reports for the company - Natalgyn Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 59.189 | 164.654 | 141.142 | 114.213 | 88.741 |
| Current Assets | - | - | - | - | - | 3.778 | 30.212 | 10.342 | 36.558 | 2.139 |
| Inventories | - | - | - | - | - | 335 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 2.633 | 1.936 | 1.189 | 792 | 0 |
| Cash | - | - | - | - | - | 810 | 28.276 | 9.153 | 35.767 | 2.139 |
| Shareholders Funds | - | - | - | - | - | 21.185 | 22.518 | 39.233 | 54.443 | 71.021 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 41.781 | 172.348 | 112.251 | 96.328 | 19.859 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Natalgyn Med S.r.l.